United StatesFenofibrate Capsules, USP 200 mg, Rx only, 100 capsules (NDC 27241-120-04), Lot PA02216, exp. 12/2029, manufactured by Ajanta Pharma Limited (India) and marketed by Ajanta Pharma USA Inc., are being recalled in the U.S. The recall was initiated because of cGMP deviations; 3,648 bottles were recalled nationwide.
What's being recalled
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Recalling firm: Ajanta Pharma USA Inc, Bridgewater, NJ, United States.
How to identify it
Lot # PA02216; Exp. 12/2029
The hazard
CGMP Deviations
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
U.S. Nationwide
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)